2025 International Congress Archives

Daily Activity Analysis of Parkinson’s Disease Using Machine Learning with 3D Poses

KD. Kim, S. Lyu, T. Dunn (Durham, USA)
Dance by Mammary: A Case of Paraneoplastic Chorea associated with Ductal Carcinoma in Situ

A. Sajjad, K. Grajny (Allentown, USA)
DBS Programming in Early Simultaneous STN-GPi Implantation for Young-Onset Parkinson’s: A Mini Case Series

P. Kahali, V. Tanoury, J. Ng, M. Ferris (Palo Alto, USA)
DBS Withdrawal Syndrome in Advanced Parkinson’s Disease: A Case Series

H. Omercikoglu Ozden, S. Irmak, D. Gunal (İstanbul, Turkey)
Deciphering differences in Functional Movement Disorders between Children and Adults

D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)
Decline in Motor Function and Cognitive Abilities in GBA PD Compared to Idiopathic PD (iPD)

B. Mangal, C. Edgar, O. Siddiqui, M. Facheris, M. Hagey, D. Weintraub, T. Simuni (Chicago, USA)
Decoding Naturalistic Movement for Adaptive Deep Brain Stimulation in Parkinson’s Disease

D. Lawrence, P. Starr, S. Little (San Francisco, USA)
Decoding Parkinson’s Progression: Longitudinal Volumetric MRI Biomarkers in Prodromal and Clinical Stages

S. Datta, M. Acharya, N. Ghosh, B. Chakraborty (Kharagpur, India)
Decreased cholinergic activity in specific brain regions associated with slower lower limb visual choice reaction time in Parkinson’s disease: A [18F]-FEOBV PET study

P. Kanel, G. Carli, J. Barr, F. Michalakis, S. Roytman, R. Vangel, P. Scott, C. Pongmala, R. Albin, N. Bohnen (Ann. Arbor, USA)
Decreased Disease Burden in Motor-Related HD-HI Domains Among Adults With Huntington’s Disease Treated With Valbenazine

E. Furr Stimming, H. Zhang, O. Klepitskaya, D. Haubenberger, S. Hinton, C. Heatwole (Houston, USA)
Decreased DTI-ALPS Indices and their Association with Clinical Features in Parkinson’s Disease

J. Pardo, I. Roura, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, J. Oltra, A. Campabadal, N. Bargalló, MA. Jurado, M. Garolera, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)
Deep Brain Stimulation (DBS) Patient Recharge Usage Data from the First 9 Months of Initially Implanted Medtronic Percept RC B35300 Neurostimulator Models.

E. Hargreaves, D. Caputo, D. Dolce, D. Perez, R. Dipaola, Y. Fernandez, S. Danish (Neptune, USA)
Deep Brain Stimulation (DBS) Placement in a Patient with Parkinson’s disease (PD) and Polyostotic Fibrous Dysplasia (PFD)

D. Kaul, P. Pezeshkian, E. Call, S. Nandipati, D. Bruce, M. Cochran Abraham, S. Khandhar (Walnut Creek, USA)
Deep Brain Stimulation and Lesional Surgery in Parkinson’s Disease: Our Experience in Santa Cruz de la Sierra, Bolivia

E. Gonzalez Delgado, J. Velasco Fortun (Santa Cruz de la Sierra, Bolivia)
Deep Brain Stimulation for Early-Onset Parkinson’s Disease: A Systematic Review and Meta-Analysis

K. Acurio-Ortiz, M. Hemeryth-Rengifo, G. Quispe-Villegas, F. Váscones-Román, V. Abuid-Sampelayo, D. Salazar-Flores, C. Quispe-Vicuña, A. Flores-Gavino, B. Avila-Lucas, M. Vilca-Salas, N. Pacheco-Barrios (Lima, Peru)
Deep Brain Stimulation in a Patient with Dystonia-Parkinsonism Secondary to a c.609G>A PLA2G6-Associated Neurodegeneration Variant

J. Patino, M. Christie (Houston, USA)
Deep Brain Stimulation in Late-Stage Parkinson’s Disease: Insights from Clinical Practice

P. Antenucci, F. Colucci, A. Gozzi, M. Pugliatti, M. Sensi (Ferrara, Italy)
Deep Brain Stimulation Increases Motivation to Obtain Larger Rewards in Parkinson’s Disease

S. Brener, E. Pegolo, A. Hahn, J. Suh, M. Scherbakova, K. Balagula, P. Lockwood, M. Apps, S. Little (Birmingham, United Kingdom)
Deep Learning-Driven Discovery of Mitochondrial Genomic Instability in Parkinson’s Disease: A Single-Cell Multi-Omics Approach

R. Fajar, A. Ureng (Sleman, Indonesia)
Deep phenotyping of Parkinson‘s disease patients with the RAB32 Ser71Arg pathogenic variant and MDSGene literature review

T. Kleinz, F. Cavallieri, M. Borsche, G. Toschi, F. Valzania, EM. Valente, P. Mitrotti, M. Avenali, S. Zittel, R. Born, M. Matarazzo, C. Shambetova, N. Griebner, L. Santinelli, M. Brand, C. Gabbert, A. Westenberger, J. Trinh, M. Radefeldt, C. Beetz, P. Bauer, N. Brüggemann, C. Klein (Reggio Emilia, Italy)
Deferiprone improves striatal dopamine by reducing neuroinflammation and oxidative stress in MPTP-induced mice model of Parkinson’s disease

HSA. Olasore, JO. Faleti (Lagos, Nigeria)
Delayed Diagnosis of Cervical Dystonia: A Case Report Highlighting the Importance of an on-time Specialist Evaluation

A. Lysandropoulos (Durham, USA)
Delirium following deep brain stimulation: An 8 year single-centre study

S. Farrand, T. Reilly, C. Monahan, G. Nair, J. Hannan, R. Blaze, M. Ghaly, K. Gomes, K. Hamilton, W. Lee, D. Thyagarajan, A. Gilligan, A. Evans (Melbourne, Australia)
Demographic Analysis of Patients with Essential Tremor (ET)

N. Aripova, L. Kenjaeva, B. Bakhtiyor, Y. Nishonova (Tashkent, Uzbekistan)
Demographic Characteristics of Women with Primary Parkinsonism

E. Tharp, J. Martinez-Lemus, J. Suescun, M. Schiess (Houston, USA)
Demographic Features, QTc Interval and Psychosis in Military Veterans with Parkinson’s disease (PD)

A. Sarwar, P. Bigner (Houston, USA)
Dentatorubral–Pallidoluysian Atrophy (DRPLA) : A case series of nine patients from western India

K. Bavdhankar, P. Agarwal, N. Jain, S. Kothari, A. Soni, S. Kharat, A. Shah, S. Jagtap (Mumbai, India)
Depression and Social Engagement in Community-Dwelling Older Adults with Parkinsonism

M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)
Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.

P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Maria Villegas-Trujillo, S. Ordoñez-Cure, M. Alejandra Vásquez-Martínez (Zaragoza, Spain)
Description Genotype/phenotype of patients with Parkinson’s disease. Report of an Argentinean cohort included in the LARGE PD Consortium.

M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, J. Etcheverry, I. Mata, C. Perandones, E. Gatto (Cleveland, USA)
Description possible enviromental exposure in AMS Latin America population

M. Cesarini, N. Gonzalez Rojas, M. Espindola, G. da Prat, JL. Etcheverry, E. Gatto (Buenos Aires, Argentina)
Design and Outcome Measures of BRAVE, a Phase 3 Study of Omaveloxolone in Pediatric Patients With Friedreich Ataxia

D. Lynch, M. Delatycki, M. França, A. Durr, E. Bertini, S. Perlman, A. Arizpe, R. Domingo-Horne, S. Fradette, S. Sinks, M. Murai, N. Folschweiller (Philadelphia, USA)
Design of ORCHESTRA Study: Practical Experiences With Foslevodopa/Foscarbidopa Treatment in Advanced Parkinson’s Disease

A. Johansson, E. Pekkonen, L. Dorresteijn, P. Schwingenschuh, J. Szász, L. Bergmann, M. O'Meara, J. Parra, M. Südmeyer (Helsinki, Finland)
Design of the Phase 2, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of ACP-204, a Novel 5-HT2A Inverse Agonist, in Adults With Lewy Body Dementia Psychosis

R. Nunez, S. Friend, B. Howell, S. Pathak, B. Dirks, X. Feng, V. Abler (San Diego, USA)
Designing a Cultural Dance Program for People with Parkinson’s Disease

J. Takata, K. Tolentino, R. Shuman, M. Look, K. Thai, E. Krening, F. Gao, L. Jaffe, T. Seto, M. Bruno (Honolulu, USA)
Detection and characterization of rare variants in NOTCH2NLC causing false negative molecular diagnosis through long-read sequencing

N. Jin, X. Zheng, W. Luo (Hangzhou, China)
Detection and classification of Parkinson’s disease from neuroimaging modalities using machine learning and artificial intelligence: a systematic review

F. Ebrahimian Sadabad, P. Honhar, S. Houshi, F. Nejati, S. Bagherieh, A. Brackett, F. Yazdanpanah, S. Cayir, M. Hosseini, H. Tagare, D. Matuskey (New Haven, USA)
Detection of Early Stage Parkinson’s Disease Using Convolutional Neural Network Models and Wearable Sensors from the Six Minute Walk Test

H. Choi, C. Youm, H. Park, J. Hwang, M. Kim (Busan, Republic of Korea)
Detection of novel acoustic biomarkers among Parkinson’s disease patients via an explainable machine learning model

K. Tsutsumi, P. Chang, S. Isfahani (San Diego, USA)
Detection of α-synuclein Seeds in Skin and CSF Samples from PPMI Participants.

L. Concha-Marambio, Y. Ma, C. Farris, R. Johnson, S. Rosete-Gonzalez, D. Murphy, K. Merchant, S. Hutten, T. Simuni, T. Tropea, M. Frasier, J. Hamer, K. Marek, T. Foroud (San Diego, USA)
Determinants of Cognitive Progression in Parkinson’s Disease: A Machine Learning Approach

AJ. Hernández-Medrano, A. Cervantes-Arriaga, MF. Medina-Pérez, D. Ulloa-Hernández, MF. Velasco-Delgado, GA. Martin-Mafud, AE. López-Lobato, D. Náfate-Wences, M. Rodríguez-Violante (Mexico City, Mexico)
Determination of the Minimal Clinically Important Difference in the Yale Global Tic Severity Scale Total Tic Score in a Pediatric Population With Tourette Syndrome Receiving Pharmacotherapy

J. Mcguire, G. Karkanias, R. Bittman, S. Atkinson, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Baltimore, USA)
Determining the Influence of Cardiovascular Interventions and Factors on developing Parkinson’s Disease: Inferences from a Data-Driven Causal Forest Model

V. Suresh, M. Hamed, D. Victor, M. Salgado (Lucknow, India)
Developing a Framework for Huntington’s Disease Care Partner Training and Support – HD Care Partner Bootcamp Series

J. Yomtoob, E. Zivin, K. Fagan, D. Bega (Chicago, USA)
Developing a novel Disease-Specific iPSC Model for Studying MSA Pathogenesis

A. Perez-Soriano, M. Alemany-Ribes, B. Crespo, F. Kohler, B. Fuste, M. Perez-Soriano, D. Cohen, R. Fernandez-Santiago, M. Ezquerra, MJ. Martí, V. Baekelandt, W. Peelaerts, R. Melki, L. Batlle-Morera, . (Barcelona, Spain)
Developing a Smartphone Application to Capture Objective Smartwatch Passive and Continuous Data to Individualize Parkinson’s Disease Patient Care

J. Jones, A. Sukhija-Cohen, J. Liu, R. Chapman, K. Karuturi, D. Mitchell, M. Bhanushali (Walnut Creek, USA)
Developing an Electronic Medical Record-Based Dystonia Tracking Tool for use in a Pediatric Hospital Setting

L. Vogt, N. Al Azri, A. Leblanc-Millar, M. Eckstein, E. Patterson, S. Silver, C. Gorodetsky (Toronto, Canada)
Developing Competency-Based Training Modules for Health Professionals in Parkinson’s Disease Management: A Review of Current Practices and Future Needs

M. Alfeky, M. Alomari, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. M. Elsayed (Giza, Egypt)
Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson’s Disease: A PPMI-based study

A. Negida, M. Barrett, SM. Fereshtehnejad, B. Berman, N. Mukhopadhyay (Toronto, Canada)
Development and Evaluation of Online Continuing Medical Education (CME) Programs Focused on Parkinson’s Disease: A Systematic Review

A. Elsayed, B. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah, M. M. Elsayed (Mansoura, Egypt)
Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)
Development and Validation of Personal Technology to Treat Hypophonia in Patients with Parkinson’s Disease

A. Klein, A. Gillespie, D. Anderson, M. Caveney, N. Sundholm (Atlanta, USA)
Development of a non-contact monitoring technology for the motor symptoms of Parkinson’s disease using Wi-Fi sensing

G. Oyama, K. Seo, M. Hirayama, T. Kadotani, R. Hosaka, S. Fujita, S. Fujii, M. Marumo, N. Hattori (Saitama, Japan)
Development of a Rating Instrument to Identify Catatonia by Virtual Viewing of Motor Assessments

N. Kadubandi, A. Elshourbagy, L. Smith, A. Balousha, P. Tacik, J. Barnett, J. Brasic (Baltimore, USA)
Development of Gene Panel by Next‐Generation Sequencing Approach for Diagnosis of Paroxysmal Movement Disorders

PS. Somanna, RS. Sampath, PLK. Kukkle, AK. Kolandaswamy, VKN. Nanjundagowda, RP. P, UR. R, KK. Kotha, PA. Agarwal, SNS. N S, AR. Raina, PKS. Kumar S, GM. Majigoudra (Bangalore, India)
Development of the Lewy Body Dementia Domain Rating Scale (LBD-DRS): A disease-specific outcome measure

E. Matar, B. Boeve, J. Kane, F. Rodriguez-Porcel, A. Schrag, S. Sikkes, J. Taylor (New South Wales, Australia)
Diabetic Striatopathy Treated with Tetrabenazine: A Case Report and Discussion on a Commonly Forgotten Stroke Mimic

A. Sovell, D. Klein (North Chicago, USA)
Diagnosis of GLUT1 Deficiency Syndrome in Adulthood

A. Taneja, T. Thomas (Dallas, USA)
Diagnostic accuracy and clinical correlates of real-time quaking-induced conversion assay on gastric biopsy in early Parkinson’s disease

C. Shin, JP. Im, JY. Han, B. Jin, KA. Woo, S. Lee, HY. Jeon, JY. Joo, HJ. Chang, JH. Shin, HJ. Kim, JM. Kim, YP. Choi, B. Jeon (Seoul, Republic of Korea)
Diagnostic accuracy of CSF tap test parameters in Normal pressure hydrocephalus: An ambispective cohort study

A. Elavarasi, S. Poudel, M. Tripathi, N. Wig, A. Srivastava, S. Kale, A. Suri, S. P, A. Garg, R. Rajan, D. Radhakrishnan, R. Singh (New Delhi, India)
Diagnostic and Treatment Delays in Normal Pressure Hydrocephalus: A Retrospective Analysis at a Tertiary Care Center

S. Chawla, P. Gupta, T. Liang (Philadelphia, USA)
Diagnostic mismatches between clinical assessment, imaging and alpha-synuclein biomarkers in parkinsonian syndromes

A. Gomez, C. Malatt, E. Hogg, E. Tan, Y. Bordelon, B. Frommel, M. Tagliati (Los Angeles, USA)
Diagnostic Work Up when Suspecting Early Onset Parkinson Disease (EOPD) Recommendations from the MDS EOPD Study Group

R. Mehanna, C. Marras, J. Fleisher, B. Post, K. Kumar, A. Noyce, R. Alcalay, H. Morris, T. Hatano, M. Salari, K. Smilowska, Y. Wu, B. Zhang, E. Tan, R. Savica (Houston, USA)
Diagnostic yield of commercial genetic testing for dystonia in a Canadian movement disorders cohort

K. Senkevich, R. Chen, A. Fasano, C. Ganos, S. Fox, A. Lang, S. Lidstone, R. Munhoz, E. Slow, A. Strafella, E. Swinkin, Z. Gan-Or, L. Kalia (Montreal, Canada)
Diagnostic yield of Whole-genome sequencing in Genetic Movement disorders

T. Joseph, A. Mchattie, Y-T. Tien, M. Saeed, N. Wood, H. Houlden, Z. Chen (London, United Kingdom)
Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses

D. Ghosh, P. Basu, S. Mondal, S. Pal (Kolkata, India)
Dietary Caffeic Acid Exhibits Neuroprotective and Neuromodulatory Effects in a Parkinsonian Rat Model by Mitigating Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis

A. Singh (Prayagraj, India)
Differences Between Clinical and Imaging Phenotypes in Phase 2 Study of ATH434 in Multiple System Atrophy

P. Trujillo, K. Hett, M. Bradbury, C. Wong, D. Stamler, D. Claassen (Nashville, USA)
Differential Effect of alpha-Synuclein on Mitochondrial Morphology in PD and MSA

O. Driskill, E. Ostrakhovitch, J. Patel, J. Stegemann, T. Yamasaki (Lexington, USA)
Differential Effect of Dopaminergic Treatment on Bradykinesia Features and Limb-kinetic Apraxia in Parkinson’s Disease

M. de Riggi, G. Paparella, A. Cannavacciuolo, D. Birreci, D. Costa, M. Passaretti, L. Angelini, M. Bologna (Rome, Italy)
Differential Motor Cortex Compensation in Parkinson’s Disease based on Putamen Neurodegeneration Laterality: Insights from EEG and [¹⁸F]FDOPA PET/CT

K. Lorek, J. Mączewska, L. Królicki, K. Markowska, M. Koszewicz, S. Budrewicz, M. Chalimoniuk, J. Marusiak (Wroclaw, Poland)
Differentiated approach to treatment and diagnosis of Parkinson’s disease

MRA. Abduvahabovna, ZUJ. Jahongir Qizi (Fergana, Uzbekistan)
Differentiated approach to treatment and diagnosis of Parkinson’s disease.

ZUJ. Jahongir Qizi, RMA. Abduvahabovna (Fergana, Uzbekistan)
Differentiating Functional Tic-like Movements from Organic Tics-Mind the Gap

A. Cherian, D. Kalikavil Puthanveedu (Thiruvananthapuram, India)
Differentiating Parkinsonism and related diseases by specific Parkinsonism patterns

JX. Wang, B. Wang, XH. Chen, W. Luo (Hangzhou, China)
Differentiating White-Matter Damage Patterns by Underlying Pathology in Corticobasal Syndrome

J. Parmera, A. Hernandez, B. Iepsen, C. Carneiro, S. Brucki, A. Coutinho (São Paulo, Brazil)
Diffusion MRI Changes Linked to α-Synuclein Seed Amplification Status in Parkinson’s Disease

S. Chiu, W. Wang, R. Chen, J. Desimone, C. Adler, S. Mehta, S. Dresler, N. Mcfarland, M. Okun, D. Vaillancourt (Scottsdale, USA)
Digital balance and gait measures show promise to track progression of Friedreich’s ataxia

V. Shah, D. Muzyka, H. Casey, J. Mcnames, M. El Gohary, K. Sowalsky, D. Safarpour, P. Carlson-Kuhta, J. Schmahmann, L. Rosenthal, S. Perlman, F. Horak, C. Gomez (Philadelphia, USA)
Digital Health Interventions for Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

RW. Liu, SR. Zhang, YF. Chen, HF. Shang (Chengdu, China)
Digital Health Technology Demonstrates Efficacy of Algorithmic DBS Programming

P. Acharyya, K. Daley, C. Casselton, A. Abay, A. Negi, S. Karjagi, K. Wilkins, M. Ferris, H. Bronte-Stewart (Stanford, USA)
Digital measurement of ocular microtremor in Parkinson’s Disease: Analytical and clinical validation

L. Graham, R. Vitorio, P. Tait, R. Walker, A. Godfrey, R. Morris, S. Stuart (Newcastle-upon-Tyne, United Kingdom)
Digital Measures for Clinical Trial Endpoints in Huntington’s Disease (MEND-HD): Study Design and Status Update

J. Adams, J. Hausdorff, J. Mammen, P. Auinger, C. Dorney, S. Mahes, N. Shah, M. Tyo, M. Bjalme-Evans, L. Quinn (Rochester, USA)
Direct Targeting Technique of The Globus Pallidus Interna in Primary Dystonia: An Analysis of The Clinical Results And Localization of DBS Electrodes

H. Eray, M. Akbostanci, A. Savas (Altindag, Turkey)
Disclosing CLIA certified genetic results within the LARGE-PD Cohort in Peru: Preliminary results of the PD GENEration study

A. Manrique-Palomino, F. Requejo-Navarro, M. Inca-Martinez, A. Rivera Valdivia, E. Sarapura-Castro, V. Marca, C. Armas, M. Illanes- Manrique, J. Rios-Pinto, K. Mejia-Rojas, A. Medina-Collque, I. Cornejo-Herrera, E. Ochoa-Valle, P. D. Hodges, R. de León, I. F. Mata, M. Cornejo-Olivas (Lima, Peru)
Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)
Disease Modifying Potential of a Novel ROCK Inhibitor in Rodent Models of Synucleinopathy

M. Kubik, J. Mackeigan, A. Stoll, J. Patterson, J. Lipton, K. Steece-Collier, A. Cole-Strauss, C. Kemp, J. Howe, K. Miller, F. Manfredsson, S. Celano, K. Luk, C. Sortwell (Grand Rapids, USA)
Disease Monitoring through the PKAN Disease Rating Scale (PKAN-DRS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN)

A. Salazar-Villacorta, R. Spaull, M. Correa-Vela, A. Cazurro, J. Ferrero Turión, A. Soo, M. González, A. Macaya, B. Pérez-Dueñas, M. Kurian (London, United Kingdom)
Disparities in Parkinson’s Disease Care Access in Hawaii

K. Thai, E. Krening, R. Shuman, M. Faouzi, G. Ross, L. Terpak, F. Gao, M. Bruno (Honolulu, USA)
Disrupted NOVA2-Mediated Splicing by (TTTCA) Repeat Expansion: Unveiling Aberrant Synaptic Gene Regulation in FCMTE1

YL. Chen, F. Zhang, ZD. Cen, W. Luo (Hangzhou, China)
Distinct Peripheral Immune Profiles of Parkinson’s Disease and Multiple System Atrophy

S. Jo, I. Jang, J. Lee, M. Choi, E. Lee, SJ. Chung (Seoul, Republic of Korea)
Distinct roles of PARK2, PINK1, and LRRK2 in neuroinflammation: resistance and susceptibility in immune-mediated mouse models

D. Cossu, H. Okada, S. Noda, Y. Tomizawa, S. Ueno, L. Sechi, T. Hatano, N. Hattori (Tokyo, Japan)
Distinguishing DBS and Non-DBS Parkinson’s Patients Using Recurrence Plots and Vision Transformers

V. Skaramagkas, G. Karamanis, I. Boura, C. Chatzaki, I. Kyprakis, D. Fotiadis, C. Spanaki, Z. Kefalopoulou, M. Tsiknakis (Estavromenos, Heraklion, Greece)
Distinguishing Functional and Essential Tremor from Tremor in Parkinson’s Disease using an objective comprehensive Motor Symptom Assessment Device

D. Bramwell, C. Papasavvas, M. Walter, A. Dimelow, A. Deutschländer, R. Zietsma (Newcastle upon Tyne, United Kingdom)
Distribution of Chronotypes in Parkinson’s Disease and its association with Pathological Sleepiness

A. Sarwar (Houston, USA)
Distribution of Genomic Ancestries and Genetic Variation Among Individuals Enrolled in the PD GENEration Study

A. Dilliott, K. Ghosh Galvelis, N. Bothwick, L. Caboy, M. Caulfield, R. de Leon, M. Dini, I. Khaderi, S. Rao, A. Yake, A. Coral Zambrano, J. Solle, C. Blauwendraat, A. Singleton, J. Beck, R. Alcalay (Miami, USA)
Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients

S. Rath, V. Holla, P. Pal, N. Kamble, R. Yadav (BANGALORE, India)
Do Peripheral Inflammatory Markers Predict Impulse Control Disorders in Parkinson’s Disease? Insights from a Retrospective Study

N. Durmaz Celi̇k, M. Yildiz, S. Ozkan (Eskisehir, Turkey)
Do We Agree? Patient and Clinician Ratings of Head Tremor in Isolated Cervical Dystonia

A. Lin, R. Pamintuan, Y. Han, M. Kim, M. Luu, R. Barbano, B. Berman, C. Comella, J. Feuerstein, H. Jinnah, D. Martino, J. Perlmutter, G. Stebbins, A. Wagle-Shukla, S. Pirio Richardson, D. Peterson (La Jolla, USA)
Does 10-year STN-DBS impact the natural progression of Parkinsons Disease? A Multicenter Retrospective Controlled Observational Study

A. Gozzi, S. Convenga, L. Romito, F. Bove, F. Cavallieri, E. Scelzo, R. Cilia, R. Eleopra, V. Fraix, A. Castrioto, AR. Bentivoglio, C. Piano, I. Isaias, A. Priori, M. Sensi, D. Azzolina, P. Pellissier, S. Meoni, E. Moro (Grenoble, France)
Does COMT Play a Role in Parkinson’s Disease Susceptibility Across Diverse Ancestral Populations?

M. Martin-Bórnez, N. Shar, M. Nour, D. Murphy, I. Elsayed, M. Shri, F. Nwaokorie, A. Olusanya, N. Kuznetsov, S. Bandres-Ciga, A. Noyce, H. Iwaki, L. Jones, P. Gómez-Garre, P. Mir, MT. Periñan (Sevilla, Spain)
Does the cerebellum compensate to enable motor learning in Parkinson’s Disease?

PC. Iyer, BE. Fisher (Los Angeles, USA)
Dopa Decarboxylase as a Biomarker for Parkinsons Disease and Its Relationship to L-Dopa Influence and Sample Size Estimates

J. Chung, A. Rhodes, P. Artoni, Y. Matsuki, K. Otake, J. Padmanabhan, D. Prilutsky (Cambridge, USA)
Dopa-Responsive Parkinsonism Secondary to Tauopathy: Clinical, Pathological, and Genetic Study

S. Giri Ravindran, B. Daud Shah, E. Noyes, V. Zherebitskiy, A. Rajput, M. Farrer, A. Rajput (Saskatoon, Canada)
Dopamine replacement therapy modulates dopa decarboxylase, prolactin and AOC3 levels in Parkinson’s disease

L. van Hillegondsberg, S. Ahmad, M. Fletcher, A. Taylor, A. Thompson, M. Hu (Oxford, United Kingdom)
Dopamine Responsive ATP1A3 Dystonia Parkinsonism A Case Report

J. Liu, T. Liu, F. Gao (Honolulu, USA)
Dopamine Transporter Imaging as a Predictor of Functional Outcomes in Parkinson’s Disease

K. Niemi, V. Kaasinen, J. Joutsa (Turku, Finland)
Dopamine-Responsive Post-Anoxic Parkinsonism

T. Liu, J. Ahlskog, J. Bower, O. Kantarci, R. Savica (Rochester, USA)
Dopaminergic and Synaptic Alterations in SWEDD: Insights from [¹⁸F] FE-PE2I and [¹¹C] UCB-J PET Imaging

F. Ebrahimian Sadabad, T. Volpi, P. Honhar, L. Colon, S. Tinaz, M. Naganawa, M. Dias, G. Angarita, R. Comley, R. Carson, S. Finnema, D. Matuskey (Tallahassee, USA)
Dopaminometer: A Smartphone-Based Application to Predict Striatal Dopaminergic Deficit in Prodromal and Manifest Parkinson’s disease

K. Gunter, K. Groenewald, J. Klein, T. Aubourg, J. Razzaque, C. Lo, P. Ratti, L. van Hillegondsberg, J. Welch, A. Nastasa, K. Bradley, D. Mcgowan, B. Orso, P. Mattioli, M. Pardini, S. Raffa, F. Massa, D. Arnaldi, S. Arora, M. Hu (Oxford, United Kingdom)
Dosage Optimization and Treatment Outcomes of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson’s Disease: a single center study

K. Kakuda, Y. Kimura, K. Ikenaka, H. Mochizuki (Suita, Japan)
Dose Optimization of Foslevodopa/Foscarbidopa: Post Hoc Analysis of Study Completers

J. Aldred, M. Bouchard, D. Kern, P. Mir, L. Bergmann, R. Gupta, M. O'Meara, J. Samuelsson, B. Bergmans (Spokane, USA)
Down-titration of levodopa complicated by catatonia

D. Newbold, . (New York, USA)
DPPX Autoimmune Encephalitis Presenting with Chorea

T. Le, S. Pradeep (Houston, USA)
Drawing Impairments Linked to Altered Cortico-Subcortical Interactions in Writer’s Cramp

M. Muthuraman, G. Deuschl, C. Ip, J. Volkmann, M. Bange (Augsburg, Germany)
Dried Plasma Spot Cards for Measurement of Neurofilament Light Chain

B. Huxford, P. Gklinos, F. Rios, N. Vickaryous, L. Schalk, A. Noyce, R. Dobson (London, United Kingdom)
Drug-Induced Movement Disorders in Elderly Patients with Dementia: A Case Study of Acute Dystonia Following Third-Generation Antipsychotic Use

A. Katok, D. Khasanova, I. Khasanov (Kazan, Russian Federation)
Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine

N. Guragain, R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)
Drug-induced parkinsonism with resting tremor

M. Nomoto, A. Watanabe (Imabari Ehime, Japan)
Dual Target Bi Pallidal Deep Brain Stimulation in Tourette Syndrome Deciphering Neurophysiology with Chronic Local Field Potential Recordings

O. Gonul Oner, A. Castrioto, M. Perreira, S. Meoni, P. Pellisier, S. Chabardes, E. Moro (Grenoble, France)
Dual task elicited premotor and supplementary motor activity as sensitive markers of mild Parkinson’s disease: an fNIRS analysis

J. Longhurst, S. Conklin, Y. Chiu (Saint Louis, USA)
Dual-task gait digital assessment unmask the association between dopaminergic deficits and gait parameters in early and prodromal Parkinson’s Disease

A. Pilotto, C. Zatti, A. Rizzardi, A. Galli, C. Hansen, J. Geritz, R. Rominjnders, E. Schaeffer, M. Catania, A. Lupini, T. Comunale, E. Premi, M. Pasolini, S. Lucchini, F. Brertagna, B. Paghera, S. Caminiti, D. Perani, D. Berg, W. Maetzler, A. Padovani (Brescia, Italy)
Duration of Illness and Response to Pimavanserin in Parkinson’s Disease Psychosis: Post-Hoc Analysis of Clinical Trial Data

K. Dashtipour, A. Espay, M. Tagliati, G. Brunson, X. Feng, N. Rashid, L. Chrones (Loma Linda, USA)
Dynamics Of Pallidal Beta Activity During Voluntary Movement In Parkinson’s Disease And Cervical Dystonia

V. Filyushkina, S. Usova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Dystonia as a Rare Manifestation of POLG-Related Disease: A Case Report

A. Medhus, L. Kovalchick, E. Krause (Austin, USA)
Dystonia associated with fluoxetine in a patient, CYP2D6*4/*4 (poor) metabolizer: role of drug-drug interactions

I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg, K. Zic (Zagreb, Croatia)
Dystonia in Cameroon: Clinical characteristic and treatment patterns

HD. Ewodo Touna, D. Gams Massi, M A. Magnerou, C. Kenmegne, E. Chokote, E. Gueumekane Bila, M. Tonga, D. Atsa Kouda, G. Nokam, Y. Mapoure Njankouo (Douala, Cameroon)
Dystonic lower limb tremor secondary to involvement of the substantia nigra in a patient with Neurotoxoplasmosis and HIV

AL. Donadon, M. da Silva, E. de Souza, A. de Mendonça, A. Fernandes, M. Munareto, C. Campos, A. Baeta, . (São Paulo, Brazil)
Dystonic Tremor as a Prognostic Marker of Deep Brain Stimulation Success in Cervical Dystonia

I. Jang (Incheon, Republic of Korea)